Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neomycin as secondary prophylaxis for irinotecan-induced diarrhea.

× No keyword cloud information.

6 in total

Review 1. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.

Authors: Rachel J Gibson; Dorothy M K Keefe; Rajesh V Lalla; Emma Bateman; Nicole Blijlevens; Margot Fijlstra; Emily E King; Andrea M Stringer; Walter J F M van der Velden; Roger Yazbeck; Sharon Elad; Joanne M Bowen
Journal: Support Care Cancer Date: 2012-11-10 Impact factor: 3.603

2. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.

Authors: Alexander Stein; Wieland Voigt; Karin Jordan
Journal: Ther Adv Med Oncol Date: 2010-01 Impact factor: 8.168

3. Therapeutic effects of a lipid transfer protein isolated from Morinda citrifolia L. (noni) seeds on irinotecan-induced intestinal mucositis in mice.

Authors: Luana David do Carmo; Gisele de Fátima Pinheiro Rangel; Liviane Maria Alves Rabelo; Tamiris de Fátima Goebel de Souza; Roberto César Pereira Lima Júnior; Deysi Viviana Tenazoa Wong; Renata Ferreira de Carvalho Leitão; Alfredo Augusto Vasconcelos da Silva; Pedro Jorge Caldas Magalhães; Andréa Santos Costa; Dyély de Carvalho Oliveira Campos; Nylane Maria Nunes de Alencar; Hermógenes David de Oliveira
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2022-07-01 Impact factor: 3.195

Review 4. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Authors: Umang Swami; Sanjay Goel; Sridhar Mani
Journal: Curr Drug Targets Date: 2013-06 Impact factor: 3.465

Review 5. Understanding and modulating mammalian-microbial communication for improved human health.

Authors: Sridhar Mani; Urs A Boelsterli; Matthew R Redinbo
Journal: Annu Rev Pharmacol Toxicol Date: 2013-10-23 Impact factor: 13.820

6. A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors.

Authors: Gayle S Jameson; John T Hamm; Glen J Weiss; Carlos Alemany; Stephen Anthony; Michele Basche; Ramesh K Ramanathan; Mitesh J Borad; Raoul Tibes; Allen Cohn; Ioana Hinshaw; Robert Jotte; Lee S Rosen; Ute Hoch; Michael A Eldon; Robert Medve; Katrina Schroeder; Erica White; Daniel D Von Hoff
Journal: Clin Cancer Res Date: 2012-11-07 Impact factor: 12.531

6 in total